287 related articles for article (PubMed ID: 29751881)
21. Advances in fibrolamellar hepatocellular carcinoma: a review.
Lim II; Farber BA; LaQuaglia MP
Eur J Pediatr Surg; 2014 Dec; 24(6):461-6. PubMed ID: 25486412
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.
Simon EP; Freije CA; Farber BA; Lalazar G; Darcy DG; Honeyman JN; Chiaroni-Clarke R; Dill BD; Molina H; Bhanot UK; La Quaglia MP; Rosenberg BR; Simon SM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):E5916-25. PubMed ID: 26489647
[TBL] [Abstract][Full Text] [Related]
23. Fine needle aspiration cytology of fibrolamellar hepatocellular carcinoma.
Suen KC; Magee JF; Halparin LS; Chan NH; Greene CA
Acta Cytol; 1985; 29(5):867-72. PubMed ID: 2996274
[TBL] [Abstract][Full Text] [Related]
24. Fibrolamellar carcinoma presenting as a pancreatic mass: case report and review of the literature.
Thirabanjasak D; Sosothikul D; Mahayosnond A; Thorner PS
J Pediatr Hematol Oncol; 2009 May; 31(5):370-2. PubMed ID: 19415023
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA.
Neumayer C; Ng D; Jiang CS; Qureshi A; Lalazar G; Vaughan R; Simon SM
Clin Cancer Res; 2023 Jan; 29(1):271-278. PubMed ID: 36302174
[TBL] [Abstract][Full Text] [Related]
26. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases.
Imkie M; Myers SA; Li Y; Fan F; Bennett TL; Forster J; Tawfik O
J Reprod Med; 2005 Aug; 50(8):633-7. PubMed ID: 16220774
[TBL] [Abstract][Full Text] [Related]
27. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.
Graham RP; Terracciano LM; Meves A; Vanderboom PM; Dasari S; Yeh MM; Torbenson MS; Cruise MW
Mod Pathol; 2016 Jun; 29(6):607-15. PubMed ID: 27015136
[TBL] [Abstract][Full Text] [Related]
28. Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model.
Toyota A; Goto M; Miyamoto M; Nagashima Y; Iwasaki S; Komatsu T; Momose T; Yoshida K; Tsukada T; Matsufuji T; Ohno A; Suzuki M; Ubukata O; Kaneta Y
Biochem Biophys Res Commun; 2022 Sep; 621():157-161. PubMed ID: 35839742
[TBL] [Abstract][Full Text] [Related]
29. Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association.
De Gaetano AM; Nure E; Grossi U; Frongillo F; Russo R; Vecchio FM; Lirosi MC; Sganga G; Felice C; Bonomo L; Agnes S
Jpn J Radiol; 2013 Oct; 31(10):706-12. PubMed ID: 23852711
[TBL] [Abstract][Full Text] [Related]
30. Fibrolamellar hepatocellular carcinoma- report of a case.
Yen JB; Chang KW
Chang Gung Med J; 2009; 32(3):336-9. PubMed ID: 19527614
[TBL] [Abstract][Full Text] [Related]
31. [Fibrolamellar hepatocellular cancer].
Ormann W
Leber Magen Darm; 1993 May; 23(3):128-31. PubMed ID: 8392127
[TBL] [Abstract][Full Text] [Related]
32. Unique genomic profile of fibrolamellar hepatocellular carcinoma.
Cornella H; Alsinet C; Sayols S; Zhang Z; Hao K; Cabellos L; Hoshida Y; Villanueva A; Thung S; Ward SC; Rodriguez-Carunchio L; Vila-Casadesús M; Imbeaud S; Lachenmayer A; Quaglia A; Nagorney DM; Minguez B; Carrilho F; Roberts LR; Waxman S; Mazzaferro V; Schwartz M; Esteller M; Heaton ND; Zucman-Rossi J; Llovet JM
Gastroenterology; 2015 Apr; 148(4):806-18.e10. PubMed ID: 25557953
[TBL] [Abstract][Full Text] [Related]
33. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
Ward SC; Waxman S
Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
[TBL] [Abstract][Full Text] [Related]
34. Fibrolamellar hepatocarcinoma: case report and review of the literature.
Bârsu M
Rom J Morphol Embryol; 1991; 37(3-4):161-6. PubMed ID: 1667604
[TBL] [Abstract][Full Text] [Related]
35. The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.
Darcy DG; Chiaroni-Clarke R; Murphy JM; Honeyman JN; Bhanot U; LaQuaglia MP; Simon SM
Oncotarget; 2015 Jan; 6(2):755-70. PubMed ID: 25605237
[TBL] [Abstract][Full Text] [Related]
36. Cytologic diagnosis of fibrolamellar carcinoma of the liver by fine-needle aspiration.
Davenport RD
Diagn Cytopathol; 1990; 6(4):275-9. PubMed ID: 1698598
[TBL] [Abstract][Full Text] [Related]
37. Fibrolamellar hepatoma.
Ruffin MT
Am J Gastroenterol; 1990 May; 85(5):577-81. PubMed ID: 2159697
[TBL] [Abstract][Full Text] [Related]
38. Fibrolamellar hepatocellular carcinoma: report of a case.
Kitabayashi K; Yokoi M; Ueno K; Saito H; Takashima S; Kurose N; Nojima T
Hepatogastroenterology; 2003; 50(54):1886-8. PubMed ID: 14696425
[TBL] [Abstract][Full Text] [Related]
39. The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
Reid LM; Sethupathy P
Hepatology; 2016 Feb; 63(2):662-4. PubMed ID: 26505878
[No Abstract] [Full Text] [Related]
40. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy.
Tanaka H; Hijioka S; Iwaya H; Mizuno N; Kuwahara T; Okuno N; Ito A; Kuraoka N; Matsumoto S; Obata M; Kurita Y; Yasuda M; Shimizu Y; Kuroda H; Sato Y; Haneda M; Sasaki E; Yatabe Y; Hara K
Intern Med; 2018 Dec; 57(24):3537-3543. PubMed ID: 30101933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
